ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,114Medicare Part D Prescriptions Filled, Including Refills

Rank: 106 out of 2035

$732K Total Retail Price of All Prescriptions

Rank: 127 out of 2035

464 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 464 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 8,776 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
AMLODIPINE BESYLATE 467 349 1 6
OMEPRAZOLE 426 328 2 5
LISINOPRIL 424 319 3 3
SIMVASTATIN 384 324 4 1
ATENOLOL 287 242 5 10
FUROSEMIDE 284 191 6 7
GABAPENTIN 252 185 7 14
PRAVASTATIN SODIUM 247 171 8 17
METFORMIN HCL 243 148 9 9
FLUTICASONE PROPIONATE 209 127 10 29
LEVOTHYROXINE SODIUM 202 155 11 4
METOPROLOL SUCCINATE 193 131 12 16
CRESTOR 182 153 13 41
ATORVASTATIN CALCIUM 181 138 14 13
HYDROCHLOROTHIAZIDE 164 126 15 12
ZOLPIDEM TARTRATE 163 116 16 21
LOSARTAN POTASSIUM 155 123 17 15
SERTRALINE HCL 138 104 18 23
METOPROLOL TARTRATE 136 116 19 8
TRAMADOL HCL 133 97 20 19
NEXIUM 131 47 21 51
CLOPIDOGREL 131 124 21 30
ALENDRONATE SODIUM 130 111 23 27
LOSARTAN-HYDROCHLOROTHIAZIDE 124 89 24 47
HYDROCODONE-ACETAMINOPHEN 120 71 S3 25 2
SINGULAIR 105 53 26 119
TRAZODONE HCL 105 68 26 50
HYDRALAZINE HCL 104 58 28 45
CLONIDINE HCL 104 71 28 61
GLIMEPIRIDE 103 84 30 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 86 31 26
AZITHROMYCIN 97 74 32 39
CITALOPRAM HBR 96 86 33 20
SYNTHROID 95 85 34 83
DIOVAN 93 85 35 76
CARVEDILOL 92 80 36 22
FAMOTIDINE 88 84 37 71
PLAVIX 84 82 38 49
RANITIDINE HCL 83 50 39 28
ALLOPURINOL 79 40 40 34
TRIAMTERENE-HCTZ 79 43 40 35
DIOVAN HCT 77 51 42 126
TAMSULOSIN HCL 77 74 42 25
FLUOXETINE HCL 76 46 44 81
POTASSIUM CHLORIDE 73 23 45 18
PANTOPRAZOLE SODIUM 69 63 46 42
KLOR-CON 10 69 46 46 193
POLYETHYLENE GLYCOL 3350 67 30 48 48
PREDNISONE 65 32 49 36
CYMBALTA 65 0 49 59
LANTUS 65 47 49 40
ZETIA 64 47 52 84
GLIPIZIDE 63 47 53 54
MONTELUKAST SODIUM 63 37 53 187
JANUVIA 60 40 55 85
SPIRONOLACTONE 60 40 55 65
MELOXICAM 59 39 57 56
AMITRIPTYLINE HCL 57 29 R 58 101
PROMETHAZINE HCL 55 30 R 59 106
GEMFIBROZIL 55 32 59 114
SPIRIVA 54 33 61 44
WARFARIN SODIUM 51 35 62 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.